Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension

被引:98
作者
Patel, Hemal H.
Zhang, Shen
Murray, Fiona
Suda, Ryan Y. S.
Head, Brian P.
Yokoyama, Utako
Swaney, James S.
Niesman, Ingrid R.
Schermuly, Ralph T.
Pullamsetti, Soni Savai
Thistlethwaite, Patricia A.
Miyanohara, Atsushi
Farquhar, Marilyn G.
Yuan, Jason X. -J.
Insel, Paul A.
机构
[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA
[5] Univ Calif San Diego, Dept Gene Therapy Program, La Jolla, CA 92093 USA
[6] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
[7] Univ Giessen, Lung Ctr, Med Clin 2 5, Giessen, Germany
关键词
statins; calcium; primary pulmonary hypertension; secondary pulmonary hypertension; NITRIC-OXIDE SYNTHASE; PROTEIN-COUPLED RECEPTOR; P42/44 MAP KINASE; PLASMA-MEMBRANE; CHOLESTEROL DEPLETION; SIGNAL-TRANSDUCTION; LIPID RAFTS; NULL MICE; IN-VIVO; DOMAIN;
D O I
10.1096/fj.07-8424com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vasoconstriction and vascular medial hypertrophy, resulting from increased intracellular [Ca2+] in pulmonary artery smooth muscle cells (PASMC), contribute to elevated vascular resistance in patients with idiopathic pulmonary arterial hypertension (IPAH). Caveolae, microdomains within the plasma membrane, contain the protein caveolin, which binds certain signaling molecules. We tested the hypothesis that PASMC from IPAH patients express more caveolin-1 (Cav-1) and caveolae, which contribute to increased capacitative Ca2+ entry (CCE) and DNA synthesis. Immunohistochemistry showed increased expression of Cav-1 in smooth muscle cells but not endothelial cells of pulmonary arteries from patients with IPAH. Subcellular fractionation and electron microscopy confirmed the increase in Cav-1 and caveolae expression in IPAH-PASMC. Treatment of IPAHPASMC with agents that deplete membrane cholesterol (methyl-beta-cyclodextrin or lovastatin) disrupted caveolae, attenuated CCE, and inhibited DNA synthesis of IPAH-PASMC. Increasing Cav-1 expression of normal PASMC with a Cav-1-encoding adenovirus increased caveolae formation, CCE, and DNA synthesis; treatment of IPAH-PASMC with siRNA targeted to Cav-1 produced the opposite effects. Treatments that down-regulate caveolin/caveolae expression, including cholesterol-lowering drugs, reversed the increased CCE and DNA synthesis in IPAH-PASMC. Increased caveolin and caveolae expression thus contribute to IPAHPASMC pathophysiology. The close relationship between caveolin/caveolae expression and altered cell physiology in IPAH contrast with previous results obtained in various animal models, including caveolin-knockout mice, thus emphasizing unique features of the human disease. The results imply that disruption of caveolae in PASMC may provide a novel therapeutic approach to attenuate disease manifestations of IPAH.-Patel, H. H., Zhang, S., Murray, F., Suda, R. Y. S., Head, B. P., Yokoyama, U., Swaney, J. S., Niesman, I. R., Schermuly, R. T., Savai Pullamsetti, S., Thistlethwaite, P. A., Miyanohara, A., Farquhar, M. G., Yuan, J. X.-J., Insel, P. A. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension.
引用
收藏
页码:2970 / 2979
页数:10
相关论文
共 66 条
[11]   Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene [J].
Deng, ZM ;
Morse, JH ;
Slager, SL ;
Cuervo, N ;
Moore, KJ ;
Venetos, G ;
Kalachikov, S ;
Cayanis, E ;
Fischer, SG ;
Barst, RJ ;
Hodge, SE ;
Knowles, JA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (03) :737-744
[12]   The regulation and pharmacology of endothelial nitric oxide synthase [J].
Dudzinski, DM ;
Igarashi, J ;
Greif, D ;
Michel, T .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :235-276
[13]   Pathobiology of pulmonary arterial hypertension [J].
Eddahibi, S ;
Morrell, N ;
D'Ortho, MP ;
Naeije, R ;
Adnot, S .
EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (06) :1559-1572
[14]   Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo - A role for the caveolin-scaffolding domain [J].
Engelman, JA ;
Chu, C ;
Lin, A ;
Jo, H ;
Ikezu, T ;
Okamoto, T ;
Kohtz, DS ;
Lisanti, MP .
FEBS LETTERS, 1998, 428 (03) :205-211
[15]   Mechanisms of disease: Pulmonary arterial hypertension [J].
Farber, HW ;
Loscalzo, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (16) :1655-1665
[16]   Caveolins and the regulation of endothelial nitric oxide synthase in the heart [J].
Feron, O ;
Balligand, JL .
CARDIOVASCULAR RESEARCH, 2006, 69 (04) :788-797
[17]  
Feron O, 2001, CIRC RES, V88, P129
[18]   Modulation of the endothelial nitric-oxide synthase caveolin interaction in cardiac myocytes - Implications for the autonomic regulation of heart rate [J].
Feron, O ;
Dessy, C ;
Opel, DJ ;
Arstall, MA ;
Kelly, RA ;
Michel, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) :30249-30254
[19]  
Fine SW, 2001, AM J CLIN PATHOL, V115, P719
[20]   Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK) [J].
Furuchi, T ;
Anderson, RGW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :21099-21104